基于次致命损伤的通用数学方法,用于改进克隆基因生存曲线在高热,放射治疗和超越时平坦化的建模

Adriana M De Mendoza1,2, Soňa Michlíková2,3, Paula S Castro4

  • 1Physics Department, Pontificia Universidad Javeriana, Carrera 7 N 40 - 62, Bogotá, 110231, Colombia.

PubMed
概括

一个新的统一数学模型 (Umodel) 准确地预测了高热 (HT) 和放射治疗 (RT) 治疗的细胞存活率,包括组合疗法和存活曲线平整. 该模型使用亚致命损伤 (SLD) 积累原理来更好地预测瘤反应.

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
90
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
146